CSIMarket
 
Integrated Biopharma Inc  (INBP)
 

Integrated Biopharma Inc's Suppliers Performance

INBP's Supply Chain




 
INBP Costs vs Sales of Suppliers Growth Integrated Biopharma Inc's cost of sales deteriorated by -16.67 % year on year, relative to one quarter ago cost of sales fell by -9.09 % in Q3.

• More on INBP Suppliers



Integrated Biopharma Inc's cost of sales deteriorated by -16.67 % year on year, compare to one quarter ago cost of sales fell by -9.09 % in Q3.

• More on INBP Suppliers




Integrated Biopharma Inc's Comment on Supply Chain


The Company sources raw materials and products from principal suppliers, including DSM Nutritional Products LLC. It has development and supply agreements with Herbalife International of America, Inc. and Herbalife International of Luxembourg S.à.R.L., subsidiaries of Herbalife, to develop, manufacture, and supply certain nutritional products. These agreements are effective from December 31, 2023, through December 31, 2025, and do not require minimum order quantities. The Company also enters into similar agreements with other customers in its contract manufacturing business. Although the nutraceutical business can be seasonal, the Company has not recently experienced seasonality impacts due to its current customer base. Manufacturing and product activities are regulated by federal agencies including the FDA, FTC, United States Postal Service, Consumer Product Safety Commission, and USDA, as well as state and local agencies. The FDA regulates the manufacturing facility as a dietary supplement manufacturing facility, while advertising claims are regulated by the USPS and FTC. The Company complies with guidelines from the United States Pharmacopoeia Convention, Inc. and other voluntary standards organizations. It follows the regulatory framework established by the Dietary Supplement Health and Education Act of 1994.

Integrated Biopharma Inc's Comment on Supply Chain


The Company sources raw materials and products from principal suppliers, including DSM Nutritional Products LLC. It has development and supply agreements with Herbalife International of America, Inc. and Herbalife International of Luxembourg S.à.R.L., subsidiaries of Herbalife, to develop, manufacture, and supply certain nutritional products. These agreements are effective from December 31, 2023, through December 31, 2025, and do not require minimum order quantities. The Company also enters into similar agreements with other customers in its contract manufacturing business. Although the nutraceutical business can be seasonal, the Company has not recently experienced seasonality impacts due to its current customer base. Manufacturing and product activities are regulated by federal agencies including the FDA, FTC, United States Postal Service, Consumer Product Safety Commission, and USDA, as well as state and local agencies. The FDA regulates the manufacturing facility as a dietary supplement manufacturing facility, while advertising claims are regulated by the USPS and FTC. The Company complies with guidelines from the United States Pharmacopoeia Convention, Inc. and other voluntary standards organizations. It follows the regulatory framework established by the Dietary Supplement Health and Education Act of 1994.







INBP's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Integrated Biopharma Inc 5.65 47.24 -1.65 50
SUBTOTAL 0.00 0.00 0.00 -


Sources: Integrated Biopharma Inc's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Integrated Biopharma Inc’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.